Why Twist Bioscience's Stock Is Trading Higher Today

Twist Bioscience TWST shares are trading higher on Tuesday after the company announced the launch of two coronavirus antibody panels to expedite research for COVID-19.

Twist Bioscience is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology.

The company's DNA synthesis platform utilizes proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead.

Twist Bioscience shares were trading up 0.99% at $59.21 on Tuesday. The stock has a 52-week high of $60.96 and a 52-week low of $18.52.